Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes

por Marotte, L, Capitao, M, Deleine, C, Beauvais, T, Cadiou, G, Perrin, J., Chérel, M, Scotet, E, Guilloux, Y, Bruchertseifer, F, Morgenstern, A, Jarry, A, Gaschet, J., Labarriere, N
Publicado 2021